Genetic dissection of myocilin glaucoma

Area of Science:

• Ophthalmology
• Genetics
• Molecular Biology

Background:

• Primary open-angle glaucoma (POAG) is a complex optic neuropathy with multifactorial etiology.
• Genetic factors, including mutations in MYOC (myocilin) and OPTN (optineurin), are implicated in POAG pathogenesis.
• MYOC mutations define a specific subtype known as myocilin glaucoma.

Purpose of the Study:

• To investigate the role of MYOC gene mutations in the development of POAG.
• To characterize the clinical and genetic spectrum of myocilin glaucoma.
• To explore the population frequency and ethnic variations of MYOC disease-causing variants (DCV).

Main Methods:

• Literature review and analysis of existing genetic and clinical data on MYOC mutations in POAG.
• Examination of inheritance patterns and clinical manifestations associated with MYOC DCV.
• Comparative analysis of MYOC DCV frequencies across different ethnic populations.

Main Results:

• MYOC mutations are identified as causal variants in POAG, leading to myocilin glaucoma.
• Clinical presentation of myocilin glaucoma is variable, ranging from typical POAG to ocular hypertension.
• The Arg46Stop mutation, though found in controls, increases POAG risk. Gln368Stop is European-specific.
• MYOC DCV frequency is similar across POAG patients of African, Caucasian, and Asian descent, but higher in the general African descendant population, contributing to POAG prevalence.

Conclusions:

• MYOC gene mutations are significant contributors to POAG, particularly myocilin glaucoma.
• Understanding MYOC variants and their population frequencies is crucial for explaining ethnic disparities in POAG prevalence.
• Environmental factors and other genetic loci interact with MYOC DCV in POAG pathogenesis.